 |
|
|
| |
Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF "Quad" Compared to Ritonavir-boosted Atazanavir plus Emtricitabine/Tenofovir DF in Treatment Na•ve HIV-1 Infected Subjects
|
| |
| |
Reported by Jules Levin
19th CROI, Seattle March 8, 2012
E DeJesus1, JK Rockstroh2, K Henry3, J-M Molina4, J Gathe5, S Ramanathan6, X Wei6, J Szwarcberg6, M Rhee6, and A Cheng6
1Orlando Immunology Center, Orlando, FL, US; 2Department of Medicine I, University of Bonn, Bonn, Germany; 3Hennepin County Medical Center, Minneapolis, MN, US; 4Saint Louis Hospital, Paris, France; 5Therapeutic Concepts P.A., Houston, TX, US; 6Gilead Sciences, Inc., Foster City, CA, US
|
| |
|
|
|
|
|
